Literature DB >> 15342849

Older age is a risk factor for the development of cardiovascular sequelae in Kawasaki disease.

Hiromi Muta1, Masahiro Ishii, Takahiko Sakaue, Kimiyasu Egami, Jun Furui, Yoko Sugahara, Teiji Akagi, Yoshikazu Nakamura, Hiroshi Yanagawa, Toyojiro Matsuishi.   

Abstract

OBJECTIVES: To clarify the characteristics of Kawasaki disease (KD) in children 6 years and older and to determine whether age is a risk factor for cardiovascular abnormalities.
METHODS: Patients who had KD and were reported between 1999 and 2000 in the 16th nationwide survey of KD in Japan (n = 15,314) were analyzed. Patients who were aged 6 years or older (older group) were matched with patients who were aged 6 months to 3 years and were treated at the same hospital (younger groups). The total number of analyzed patients was 1498 (749 matched pairs).
RESULTS: The proportion of complete KD in the older group was similar to that in the younger group. Recurrent cases in the older group were significantly more common than those in the younger group (9% vs 2%). The proportion of patients who were treated with intravenous gamma-globulin in the older group was significantly lower than that in the younger group (82% vs 87%). The proportion of older group patients who were treated with intravenous gamma-globulin at or after 7 days of illness was significantly higher than that in the younger group (35% vs 14%). There was a higher prevalence of cardiovascular abnormalities in the older group than in the younger group (20% vs 15%). Multivariate logistic regression analysis showed that older age was an independent risk factor for cardiovascular sequelae (odds ratio: 1.58; 95% confidence interval: 1.01-2.46).
CONCLUSIONS: In children older than 6 years, age is an independent risk factor for cardiovascular sequelae in KD.

Entities:  

Mesh:

Year:  2004        PMID: 15342849     DOI: 10.1542/peds.2003-0118-F

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  12 in total

1.  Acute tonsillitis: an unusual presentation of Kawasaki syndrome: a case report and review of the literature.

Authors:  H R Hathursinghe; S Patel; H S Uppal; J Ray
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-11-22       Impact factor: 2.503

2.  Infliximab treatment for pediatric refractory Kawasaki disease.

Authors:  Laura L Blaisdell; Jennifer A Hayman; Adrian M Moran
Journal:  Pediatr Cardiol       Date:  2011-07-20       Impact factor: 1.655

3.  Cardiovascular Outcomes During Index Hospitalization in Children with Kawasaki Disease in Ontario, Canada.

Authors:  Cal Robinson; Megan Schlorff; Rahul Chanchlani; Anastasia Gayowsky; Elizabeth Darling; Tapas Mondal; Hsien Seow; Michelle Batthish
Journal:  Pediatr Cardiol       Date:  2022-09-08       Impact factor: 1.838

4.  Risk factors for Kawasaki disease-associated coronary abnormalities differ depending on age.

Authors:  DooIl Song; Yunku Yeo; KeeSoo Ha; GiYoung Jang; JungHwa Lee; KwangChul Lee; ChangSung Son; JooWon Lee
Journal:  Eur J Pediatr       Date:  2009-01-22       Impact factor: 3.183

5.  Performance of 2004 American Heart Association recommendations for treatment of Kawasaki disease.

Authors:  Elizabeth S Yellen; Kimberlee Gauvreau; Masato Takahashi; Jane C Burns; Stanford Shulman; Annette L Baker; Nancy Innocentini; Chiara Zambetti; Joan M Pancheri; Adam Ostrow; Jeffrey R Frazer; Robert P Sundel; David R Fulton; Jane W Newburger
Journal:  Pediatrics       Date:  2010-01-25       Impact factor: 7.124

6.  Cardiac lesions and initial laboratory data in Kawasaki disease: a nationwide survey in Japan.

Authors:  Masanari Kuwabara; Mayumi Yashiro; Kazuhiko Kotani; Satoshi Tsuboi; Ryusuke Ae; Yosikazu Nakamura; Hiroshi Yanagawa; Tomisaku Kawasaki
Journal:  J Epidemiol       Date:  2015-01-10       Impact factor: 3.211

7.  Epidemiologic features of Kawasaki disease in Japan: results of the 2007-2008 nationwide survey.

Authors:  Yosikazu Nakamura; Mayumi Yashiro; Ritei Uehara; Atsuko Sadakane; Izumi Chihara; Yasuko Aoyama; Kazuhiko Kotani; Hiroshi Yanagawa
Journal:  J Epidemiol       Date:  2010-06-05       Impact factor: 3.211

8.  Epidemiologic features and prognostic factors of coronary artery lesions associated with Kawasaki disease based on a 13-year cohort of consecutive cases identified by complete enumeration surveys in Wakayama, Japan.

Authors:  Naomi Kitano; Hiroyuki Suzuki; Takashi Takeuchi; Tomohiro Suenaga; Nobuyuki Kakimoto; Shoichi Shibuta; Norishige Yoshikawa; Tatsuya Takeshita
Journal:  J Epidemiol       Date:  2014-07-05       Impact factor: 3.211

9.  Epidemiologic features of Kawasaki disease in Japan: results from the nationwide survey in 2005-2006.

Authors:  Yosikazu Nakamura; Mayumi Yashiro; Ritei Uehara; Izumi Oki; Makoto Watanabe; Hiroshi Yanagawa
Journal:  J Epidemiol       Date:  2008-07-18       Impact factor: 3.211

10.  Neutrophil-to-lymphocyte ratio and scoring system for predicting coronary artery lesions of Kawasaki disease.

Authors:  Ling-Sai Chang; Yi-Ju Lin; Jia-Huei Yan; Mindy Ming-Huey Guo; Mao-Hung Lo; Ho-Chang Kuo
Journal:  BMC Pediatr       Date:  2020-08-24       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.